mHealth Solutions Market

The global mHealth solutions market is forecast to reach USD 275.44 billion by 2031, up from USD 109.05 billion in 2026, at a CAGR of 20.4% over the forecast period. The growing adoption of remote patient monitoring (RPM) is driving market growth by enabling healthcare providers to monitor patients outside traditional clinical settings through connected medical devices and mobile health platforms. In the US, nearly 1 million Medicare enrollees received RPM services in 2024, a 27% increase from 2023, while Medicare payments for RPM rose 31% to USD 536 million, compared with USD 408 million in 2023. In the UK, the expansion of NHS virtual wards is accelerating RPM adoption by enabling patients to receive hospital-level care at home via connected medical devices and mobile applications. The growing integration of RPM into routine care is therefore increasing demand for connected medical devices, mHealth applications, data-management platforms, and remote healthcare services, supporting the overall growth of the mHealth solutions market.

The prominent players operating in the mHealth solutions market include Medtronic (Ireland), Abbott (US), Koninklijke Philips N.V. (Netherlands), Resmed (US), Dexcom, Inc. (US), Omron Healthcare (Japan), and others. These companies have adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the mHealth solutions market. These players have incorporated various organic and inorganic strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions, to strengthen their international footprint and capture a greater share of the mHealth solutions market. These organic and inorganic strategies have allowed the market to expand across geographies by offering coding solutions.

To know about the assumptions considered for the study download the pdf brochure

In May 2026, Philips, Cuviva, and Vingmed were selected to support Region Stockholm’s hospital-at-home program, which uses connected devices, remote monitoring, and digital communication to enable continuous care for patients with chronic and complex conditions. The up-to-eight-year program is expected to serve more than 2 million people, underscoring the growing adoption of mHealth and home-based connected care.

In December 2025, Dexcom launched the Dexcom G7 15-Day Continuous Glucose Monitoring (CGM) System in the US for adults 18 and older with diabetes. The new sensor provides up to 15.5 days of wear, compared with 10.5 days for the standard G7, reducing the frequency of sensor replacements.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. is a global health technology company focused on improving healthcare delivery through advanced medical technologies, connected care, and digital health solutions. The company operates across Diagnosis & Treatment, Connected Care, and Personal Health, with its Connected Care business particularly relevant to the mHealth solutions market. Its portfolio includes patient monitoring systems, remote patient monitoring, healthcare informatics, connected medical devices, sleep and respiratory care solutions, and digital health platforms that enable continuous monitoring and home-based care. Philips increasingly integrates AI, cloud connectivity, data analytics, and virtual-care technologies into its solutions to support personalized and proactive healthcare.

Medtronic (Ireland)

Medtronic is a global medical technology company focused on developing and manufacturing devices and therapies across cardiovascular, neuroscience, medical-surgical, and diabetes care. The company has strong businesses in cardiovascular, neuroscience, and diabetes. For the mHealth solutions market, Medtronic is particularly relevant through its connected medical devices, remote monitoring, digital therapy-management platforms, and diabetes technologies. Its portfolio includes solutions such as CareLink for remote monitoring of implanted cardiac devices, MiniMed diabetes technologies, and digital platforms supporting neuromodulation and patient management. These solutions connect medical devices with software and healthcare-provider platforms, enabling continuous patient monitoring, remote therapy management, and data-driven disease management.

MARKET RANKING

The ranking of companies in the mHealth solutions market is based on a market share analysis conducted after thorough secondary research and validated by primary respondents. The ranking considers factors such as revenue from mHealth solutions, product portfolio breadth and depth, innovation, and product launches. Based on this analysis, the leading market players are Medtronic (Ireland), Abbott (US), Koninklijke Philips N.V. (Netherlands), Resmed (US), Dexcom, Inc. (US), and Omron Healthcare (Japan). Their portfolios span a broad range of connected healthcare solutions, including remote patient monitoring, connected medical devices, mobile health applications, cloud-based health data platforms, digital disease management, and patient engagement tools. These offerings enable continuous monitoring of conditions such as diabetes, cardiovascular and respiratory diseases, facilitate real-time data sharing between patients and healthcare providers, and support personalized and home-based care.

Related Reports:

mHealth Solutions Market by Offering [Apps (Chronic Care, Mental Health, Women's Health, Medication Management, Fitness, CDS), Devices (Sleep, Drug Delivery)], Use Case (Preventive, Monitoring), End User (Providers, Patients) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]